Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient recruited in phase II study of ASN-002 in combination with vismodegib

Aug. 14, 2020

Healx enters a new partnership to accelerate development of therapeutics for Angelman Syndrome

Aug. 14, 2020

Theralase re-initiates phase II study of TLD-1433 in Canada

Aug. 14, 2020

New PTP-2C inhibitors disclosed by Betta Pharmaceuticals

Aug. 14, 2020

Jiangsu Chia Tai Tianqing Pharmaceutical Group presents AKT inhibitors

Aug. 14, 2020

Exelixis synthesizes new AXL and/or MERTK inhibitors

Aug. 14, 2020

SCO-267 improves liver parameters in a mouse model of NAFLD

Aug. 14, 2020

Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical patent JAK-2, TYK2 inhibitors

Aug. 14, 2020

New MNK1 and MNK2 inhibitors identified at Novostar Pharmaceuticals

Aug. 14, 2020

Minghui Pharmaceutical discovers nucleoside derivatives

Aug. 14, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...